137 related articles for article (PubMed ID: 27551460)
1. Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2.
Gurgis F; Åkerfeldt MC; Heng B; Wong C; Adams S; Guillemin GJ; Johns TG; Chircop M; Munoz L
Cell Death Discov; 2015; 1():15028. PubMed ID: 27551460
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling.
Phoa AF; Browne S; Gurgis FM; Åkerfeldt MC; Döbber A; Renn C; Peifer C; Stringer BW; Day BW; Wong C; Chircop M; Johns TG; Kassiou M; Munoz L
Biochem Pharmacol; 2015 Dec; 98(4):587-601. PubMed ID: 26519552
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
4. CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.
Li Y; Zhang D; Yu K; Hu Y; Wu Q; Qian F; Wang Z
Biol Res; 2018 Apr; 51(1):11. PubMed ID: 29661232
[TBL] [Abstract][Full Text] [Related]
5. A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells.
Chelsky ZL; Yue P; Kondratyuk TP; Paladino D; Pezzuto JM; Cushman M; Turkson J
Mol Pharmacol; 2015 Sep; 88(3):524-33. PubMed ID: 26138072
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
Gurgis FM; Ziaziaris W; Munoz L
Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation.
Haines JD; Fang J; Mushynski WE; Almazan G
Glia; 2010 Aug; 58(11):1384-93. PubMed ID: 20607863
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
[TBL] [Abstract][Full Text] [Related]
9. Small molecule targeting of the p38/Mk2 stress signaling pathways to improve cancer treatment.
Alimbetov D; Umbayev B; Tsoy A; Begimbetova D; Davis T; Kipling D; Askarova S
BMC Cancer; 2023 Sep; 23(1):895. PubMed ID: 37740222
[TBL] [Abstract][Full Text] [Related]
10. MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells.
Phoa AF; Recasens A; Gurgis FMS; Betts TA; Menezes SV; Chau D; Nordfors K; Haapasalo J; Haapasalo H; Johns TG; Stringer BW; Day BW; Buckland ME; Lalaoui N; Munoz L
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32168910
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) Inhibitors.
Qin J; Dhondi P; Huang X; Aslanian R; Fossetta J; Tian F; Lundell D; Palani A
ACS Med Chem Lett; 2012 Feb; 3(2):100-5. PubMed ID: 24900435
[TBL] [Abstract][Full Text] [Related]
12. The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.
Gurgis FM; Yeung YT; Tang MX; Heng B; Buckland M; Ammit AJ; Haapasalo J; Haapasalo H; Guillemin GJ; Grewal T; Munoz L
Oncogene; 2015 May; 34(22):2934-42. PubMed ID: 25088200
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.
Nguyen Ho-Bouldoires TH; Clapéron A; Mergey M; Wendum D; Desbois-Mouthon C; Tahraoui S; Fartoux L; Chettouh H; Merabtene F; Scatton O; Gaestel M; Praz F; Housset C; Fouassier L
Free Radic Biol Med; 2015 Dec; 89():34-46. PubMed ID: 26169728
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase p38 regulates Krox-20 to direct Schwann cell differentiation and peripheral myelination.
Hossain S; de la Cruz-Morcillo MA; Sanchez-Prieto R; Almazan G
Glia; 2012 Jul; 60(7):1130-44. PubMed ID: 22511272
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
17. MK2 plays an important role for the increased vascular permeability that follows thermal injury.
Wu W; Huang Q; Miao J; Xiao M; Liu H; Zhao K; Zhao M
Burns; 2013 Aug; 39(5):923-34. PubMed ID: 23465795
[TBL] [Abstract][Full Text] [Related]
18. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.
Singh RK; Najmi AK
Curr Drug Targets; 2019; 20(4):367-379. PubMed ID: 30112991
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
